TRACON Pharmaceuticals (TCON): O‘sish sur’atiga tuzatilgan narx-foyda
TRACON Pharmaceuticals (TCON) barqarorligi global sinov xarajatlarining hamkorlar o'rtasida taqsimlanishi bilan ta'minlanadi, bu esa kompaniyaning baholanishi va uning o'sish sur'atlari o'rtasidagi bog'liqlikni tasdiqlaydi. Kapital royalti to'lovlari va maqsadli terapiya uchun oldindan to'lovlarga asoslangan, garchi asosiy tadqiqotning muvaffaqiyatsizligi ba'zi aktivlarning tugatilishiga olib kelgan bo'lsa-da. 0.00 qiymati oxirgi metrika qiymatini aks ettiradi va biznes istiqbollarining joriy bozor bahosini ko'rsatadi.
TRACON Pharmaceuticals (TCON) kompaniyasining tahliliy kesimlari
- bozor narxi va tahlilchilarning maqsadli narxlari:
- birja kapitallashuvi ma'lumotlari:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Jamlagan qarzning xususiy kapitalga nisbati TRACON Pharmaceuticals|TCON - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati traconpharma.com|TCON - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar TRACON|TCON - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari TRACON Pharmaceuticals|Tezkor likvidlik ko‘rsatkichi traconpharma.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
TCON - Sof foyda|Prognoz qilingan kelajakdagi foyda TRACON Pharmaceuticals|TCON - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati TRACON Pharmaceuticals, Inc|TCON - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati TRACON|TCON - Eskirish chegirilmasdan oldingi operatsion foyda|Bir aksiya uchun sof foyda (EPS TTM) TRACON Pharmaceuticals|TCON - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sish sur'ati traconpharma.com|TCON - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi TRACON Pharmaceuticals
Kompaniyaning umumiy tahlili:TCON TRACON Pharmaceuticals Inc.
Ushbu ko'rsatkich foydaning bozor qiymatini uning o'sish sur'atiga bog'laydi va kengayish dinamikasi joriy aksiya narxini oqlash-oklamasligini aniqlaydi. Normallashtirilgan PEG ko'rsatkichining birdan past bo'lishi aktivlarning qadriyatidan past baholanganligini anglatadi, bu esa TRACON Pharmaceuticals (TCON) uchun patent nizolari bo'yicha to'lovlarni yoki klinik platformasining monetizatsiyasini kutayotganda, spekulyativ o'sishni fundamental aktivga aylantirishda muhim ahamiyatga ega.
TRACON Pharmaceuticals raqobatchilari
Narx-foyda va o‘sish multiplikatori Tempus AI, Inc TEM|Narxning foydaga va o‘sish sur’atiga nisbati Qiagen Group QGEN|Isis Pharmaceuticals (IONS) - O‘sish sur’atiga tuzatilgan narx-foyda|RGEN - Narxning foydaga va o‘sish sur’atiga nisbati|RNA (aviditybiosciences.com) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|CRSP (CRISPR Therapeutics) - Narx-foyda va o‘sish multiplikatori|GeneDx Holdings - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Ultragenyx Pharma|Beam Tx - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori SRPT|TWST (twistbioscience.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori TXG (10x Genomics)|PEG multiplikatori Intellia Therapeutics Inc NTLA|STOK - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti BLFS (BioLife)|Wave Life Sciences (WVE) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori mazetx.com|SION (Sionna Therapeutics) - PEG multiplikatori|PEG multiplikatori Prime Medicine Inc|PEG multiplikatori TSHA|Narx-foyda va o‘sish multiplikatori uniQure Pharma QURE|PEG multiplikatori MGTX (MeiraGTx Holdings plc)|regenxbio.com (RGNX) - O‘sish sur’atiga tuzatilgan narx-foyda|SLDB: Narx-foyda va o‘sish multiplikatori|OCGN - PEG multiplikatori|PACB (Pacific Biosciences of California) - Narx-foyda va o‘sish multiplikatori|BNTC: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|DSGN (Design Therapeutics) - PEG multiplikatori|rocketpharma.com (RCKT) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori FDMT|Narx-foyda va o‘sish multiplikatori lexeotx.com LXEO|PEG multiplikatori KRRO (Korro Bio)|PEG multiplikatori Editas Corp EDIT|SLN - Narxning foydaga va o‘sish sur’atiga nisbati|PRQR: Narxning foydaga va o‘sish sur’atiga nisbati|codexis.com (CDXS) - Narxning foydaga va o‘sish sur’atiga nisbati|SGMO - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori NAUT|MGX (Metagenomi Therapeutics) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori DTIL|Narx-foyda va o‘sish multiplikatori generationbio.com GBIO|Narxning foydaga va o‘sish sur’atiga nisbati Boundless Bio BOLD|Exicure Inc. (XCUR) - O‘sish sur’atiga tuzatilgan narx-foyda|IMNN - Narxning foydaga va o‘sish sur’atiga nisbati|PHIO (Phio Pharmaceuticals) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|MBIO: PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti RNAZ|Narxning foydaga va o‘sish sur’atiga nisbati Bionano Genomics Inc.|O‘sishni hisobga olgan narx-foyda koeffitsiyenti APDN (Applied DNA Sciences Inc)|PEG multiplikatori BLUE|PEG multiplikatori immunoprecise.com (IPA)|Omega Therapeutics - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati OMIC (singulargenomics.com)|RGLS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti SYRS (Syros Pharmaceuticals Inc.)|TBIO: PEG multiplikatori|Unity Biotechnology, Inc (UBX) - PEG multiplikatori
